183 related articles for article (PubMed ID: 20002304)
1. Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C.
Tsochatzis E; Papatheodoridis GV; Koliaraki V; Hadziyannis E; Kafiri G; Manesis EK; Mamalaki A; Archimandritis AJ
J Viral Hepat; 2010 Nov; 17(11):800-6. PubMed ID: 20002304
[TBL] [Abstract][Full Text] [Related]
2. Serum prohepcidin levels correlate with hepatic iron stores in chronic hepatitis C patients.
Lin TJ; Liao LY; Chou JM; Liu SO; Wang CK
Hepatogastroenterology; 2009; 56(93):1146-51. PubMed ID: 19760959
[TBL] [Abstract][Full Text] [Related]
3. Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C.
Aoki CA; Rossaro L; Ramsamooj R; Brandhagen D; Burritt MF; Bowlus CL
J Clin Gastroenterol; 2005 Jan; 39(1):71-4. PubMed ID: 15599216
[TBL] [Abstract][Full Text] [Related]
4. Circulating level of large splice variants of tenascin-C is a marker of piecemeal necrosis activity in patients with chronic hepatitis C.
Tanaka H; El-Karef A; Kaito M; Kinoshita N; Fujita N; Horiike S; Watanabe S; Yoshida T; Adachi Y
Liver Int; 2006 Apr; 26(3):311-8. PubMed ID: 16584393
[TBL] [Abstract][Full Text] [Related]
5. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
[TBL] [Abstract][Full Text] [Related]
6. Plasma prohepcidin levels in patients with chronic viral hepatitis: relationship with liver fibrosis.
Olmez OF; Gurel S; Yilmaz Y
Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):461-5. PubMed ID: 19940783
[TBL] [Abstract][Full Text] [Related]
7. The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis.
Tan TC; Crawford DH; Franklin ME; Jaskowski LA; Macdonald GA; Jonsson JR; Watson MJ; Taylor PJ; Fletcher LM
Liver Int; 2012 Oct; 32(9):1391-9. PubMed ID: 22676252
[TBL] [Abstract][Full Text] [Related]
8. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
[TBL] [Abstract][Full Text] [Related]
9. Increased serum hepcidin levels in patients with porphyria cutanea tarda.
Darwich E; To-Figueras J; Molina-López RA; Deulofeu R; Olbina G; Westerman M; Sánchez-Tápias JM; Muñoz-Santos C; Herrero C
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e68-74. PubMed ID: 22429447
[TBL] [Abstract][Full Text] [Related]
10. Correlation of serum alanine aminotransferase and aspartate aminotransferase levels to liver histology in chronic hepatitis C.
Nadeem A; Hussain MM; Aslam M
J Coll Physicians Surg Pak; 2010 Oct; 20(10):657-61. PubMed ID: 20943107
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
[TBL] [Abstract][Full Text] [Related]
12. Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase-2 in patients with HCV-related chronic hepatitis. Relationship to histological features.
Bruno CM; Valenti M; Bertino G; Ardiri A; Consolo M; Mazzarino CM; Amoroso A; Neri S
Panminerva Med; 2009 Dec; 51(4):191-6. PubMed ID: 20195229
[TBL] [Abstract][Full Text] [Related]
13. Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C.
Yadav D; Hertan HI; Schweitzer P; Norkus EP; Pitchumoni CS
Am J Gastroenterol; 2002 Oct; 97(10):2634-9. PubMed ID: 12385452
[TBL] [Abstract][Full Text] [Related]
14. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.
Giannini E; Ceppa P; Botta F; Mastracci L; Romagnoli P; Comino I; Pasini A; Risso D; Lantieri PB; Icardi G; Barreca T; Testa R
Am J Gastroenterol; 2000 Nov; 95(11):3211-7. PubMed ID: 11095344
[TBL] [Abstract][Full Text] [Related]
15. [The effect of tobacco smoking during pregnancy on concentration of pro-hepcidin and some parameters of iron metabolism in matched-maternal cord pairs].
Chełchowska M; Lewandowski L; Ambroszkiewicz J; Swiatek E; Gajewska J; Ołtarzewski M; Laskowska-Klita T
Przegl Lek; 2008; 65(10):474-8. PubMed ID: 19189526
[TBL] [Abstract][Full Text] [Related]
16. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
Fujita N; Horiike S; Sugimoto R; Tanaka H; Iwasa M; Kobayashi Y; Hasegawa K; Ma N; Kawanishi S; Adachi Y; Kaito M
Free Radic Biol Med; 2007 Feb; 42(3):353-62. PubMed ID: 17210448
[TBL] [Abstract][Full Text] [Related]
17. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.
Giannini E; Botta F; Cataldi A; Tenconi GL; Ceppa P; Barreca T; Testa R
Hepatogastroenterology; 1999; 46(28):2422-5. PubMed ID: 10522010
[TBL] [Abstract][Full Text] [Related]
18. Liver hepcidin mRNA expression is inappropriately low in alcoholic patients compared with healthy controls.
Costa-Matos L; Batista P; Monteiro N; Simões M; Egas C; Pereira J; Pinho H; Santos N; Ribeiro J; Cipriano MA; Henriques P; Girão F; Rodrigues A; Carvalho A
Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1158-65. PubMed ID: 22732356
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant levels in peripheral blood, disease activity and fibrotic stage in chronic hepatitis C.
Bandara P; George J; McCaughan G; Naidoo D; Lux O; Salonikas C; Kench J; Byth K; Farrell GC
Liver Int; 2005 Jun; 25(3):518-26. PubMed ID: 15910488
[TBL] [Abstract][Full Text] [Related]
20. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]